Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07362407 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Analysis of the Therapeutic and Clinical Profile of Cannabinoid Treatments: A Real-World Study

Study acronym: CANAREAL
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 30, 2026 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status changed: Not Yet Recruiting → Enrolling by Invitation
    • Start date changed from estimate of Feb 2026 to Mar 1, 2026
    • Interventions: Participants are followed while using cannabis-based products (such as CBD or THC oils, extracts, or isolates) as prescribed by their own… to Participants are followed while using cannabis-based products (such as CBD or THC oils, extracts, or isolates) as prescribed by their own…
    • Site contact updated
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
What is the purpose of this study? The use of medicinal cannabis has grown significantly in Brazil. However, because many patients use these products through "compassionate use" (when traditional treatments haven't worked), there is still a lack of large-scale data on how these treatments perform in daily life. This study, called CANAREAL, aims to track patients across Brazil to understand if cannabis-based products are truly effective and safe for treating various conditions, such as chronic pain, anxiety, and depression. How will the study work? This is an observational study, which means the researchers will not provide the medication or change the treatment prescribed by the patient's doctor. Instead, we will simply "follow" the patient's journey for 6 months. What will participants be asked to do? Participants will complete online questionnaires at different stages of their treatment. These tools will measure: Quality of Life: How the treatment affects daily well-being. Clinical Evolution: Changes in pain levels, anxiety, and depression symptoms. Safety: Whether the patient experiences any side effects (adverse events). Why is this study important? Unlike controlled laboratory tests, this "Real-World Study" captures the reality of diverse patients with different backgrounds and health needs. The information gathered will help doctors, patients, and health authorities in Brazil better understand the benefits and risks of cannabinoid therapy, leading to safer and more informed medical decisions in the future.
Trial Details
NCT Number NCT07362407
Lead Sponsor Santa Catarina Federal University
Collaborators: HempMeds Brasil
Conditions
(from sponsor)		 Chronic Pain, Depression Disorders, Anxiety Disorders, Quality of Life, Cannabidiol Effects, Cannabinoids
Related terms Anxiety Disorders, Chronic Pain, Color Vision Defects, Marijuana Abuse, Wiskott-Aldrich Syndrome
Enrollment 384 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov